Key Dates

Related Announcements

• May 17, 2023 - Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed). See NOFO RFA-AG-24-038.

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants of a change to the Eligibility Information in Notice of Funding Opportunity (NOFO) RFA-AG-24-038, "Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed).”

The following information under Part 2, Section III.1 Eligible Applicants of RFA-AG-24-038 has been modified:

Foreign Institutions

Currently reads:

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

Modified to read (changes shown in bold italics):

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Nalini Raghavachari, Ph.D.
Division of Geriatrics and Clinical Gerontology
National Institute on Aging (NIA)
Telephone: 301-496-6942
Email: [email protected] 

Hongwei Gao, M.D., Ph.D.
Division of Aging Biology
National Institute on Aging (NIA)
Telephone: 301-402-9778
Email: [email protected]